Anemia in Atrial Fibrillation Linked to Increased Bleeding Risk
Anemia in patients with atrial fibrillation is associated with major bleeding and lower time in therapeutic range.
Anemia in patients with atrial fibrillation is associated with major bleeding and lower time in therapeutic range.
Investigators conducted an analysis to determine lymphoma events to characterize lymphomas occurring during the tofacitinib RA clinical development program.
The FDA has issued new warnings on the increased incidence of lymphoma among patients receiving golimumab in clinical trials.